An Evaluation of The Absolute Bioavailability of TH104
Clinical trial NCT06198686 · COMPLETED
Trial details
- NCT number
- NCT06198686
- Sponsor
- Tharimmune Inc
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-01-26
- Primary completion
- 2024-02-11
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.